Back
Karyopharm Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
21
KPTI
Karyopharm Therapeutics
Last Price:
$4.86
Seasonality Move:
-6.23%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KPTI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Karyopharm Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.58 | Sell |
| 20-day SMA: | 4.49 | Buy |
| 50-day SMA: | 4.91 | Sell |
| 200-day SMA: | 8.46 | Sell |
| 8-day EMA: | 3.01 | Buy |
| 20-day EMA: | 1.57 | Buy |
| 50-day EMA: | 0.7 | Buy |
| 200-day EMA: | 0.19 | Buy |
Karyopharm Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.06 | Buy |
| Relative Strength Index (14 RSI): | 49.22 | Sell |
| Chaikin Money Flow: | 1625219 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.28 - 4.64) | Buy |
| Bollinger Bands (100): | (4.02 - 6.98) | Sell |
Karyopharm Therapeutics Technical Analysis
| Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Karyopharm Therapeutics Stock
Is Karyopharm Therapeutics Stock a Buy?
-
Karyopharm Therapeutics share price is 4.55 while KPTI 8-day simple moving average is 4.58, which is a Sell signal.
-
The stock price of KPTI is 4.55 while Karyopharm Therapeutics 20-day SMA is 4.49, which makes it a Buy.
-
Karyopharm Therapeutics 50-day simple moving average is 4.91 while KPTI share price is 4.55, making it a Sell technically.
-
KPTI stock price is 4.55 and Karyopharm Therapeutics 200-day simple moving average is 8.46, creating a Sell signal.
KPTI Technical Analysis vs Fundamental Analysis
Sell
21
Karyopharm Therapeutics (KPTI)
is a Sell
Is Karyopharm Therapeutics a Buy or a Sell?
-
Karyopharm Therapeutics stock is rated a SellThe current Karyopharm Therapeutics [KPTI] share price is $4.55. The Score for KPTI is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Karyopharm Therapeutics Stock Info
Market Cap:
39.3M
Price in USD:
4.55
Share Volume:
1.7M
Karyopharm Therapeutics 52-Week Range
52-Week High:
16.95
52-Week Low:
3.51
Sell
21
Karyopharm Therapeutics (KPTI)
is a Sell
Karyopharm Therapeutics Share Price Forecast
-
What is the Karyopharm Therapeutics stock price today?The Karyopharm Therapeutics stock price is 4.55 USD today.
-
Will KPTI stock go up or go down?Karyopharm Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Karyopharm Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Karyopharm Therapeutics is overvalued.
Is Karyopharm Therapeutics Stock a Buy?
-
Karyopharm Therapeutics share price is 4.55 while KPTI 8-day exponential moving average is 3.01, which is a Buy signal.
-
The stock price of KPTI is 4.55 while Karyopharm Therapeutics 20-day EMA is 1.57, which makes it a Buy.
-
Karyopharm Therapeutics 50-day exponential moving average is 0.70 while KPTI share price is 4.55, making it a Buy technically.
-
KPTI stock price is 4.55 and Karyopharm Therapeutics 200-day simple moving average is 0.19, creating a Buy signal.
Fundamental Analysis of Karyopharm Therapeutics
Is Karyopharm Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.57 per share, a decrease next quarter of $0.57 per share, a decrease this year of $1.91 per share, and an increase next year of $3.16 per share.
Technical Analysis of Karyopharm Therapeutics
Should I short Karyopharm Therapeutics stock?
-
KPTI Moving Average Covergence Divergence (MACD) indicator is 1.06, suggesting Karyopharm Therapeutics is a Buy
-
Karyopharm Therapeutics Relative Strength Index (RSI) is 49.22, which suggest Karyopharm Therapeutics is oversold
-
The Bollinger Bands (25) for Karyopharm Therapeutics is (4.28 - 4.64), which suggest Karyopharm Therapeutics is a Sell
-
The Bollinger Bands (100) for Karyopharm Therapeutics is (4.02 - 6.98), which suggest Karyopharm Therapeutics is a Sell
* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.